175 related articles for article (PubMed ID: 11345238)
1. Pancreatic acinar cell carcinoma.
Ordóñez NG
Adv Anat Pathol; 2001 May; 8(3):144-59. PubMed ID: 11345238
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours.
Kim JY; Brosnan-Cashman JA; Kim J; An S; Lee KB; Kim H; Park DY; Jang KT; Oh YH; Hruban RH; Heaphy CM; Hong SM
Pathology; 2020 Apr; 52(3):336-347. PubMed ID: 32111396
[TBL] [Abstract][Full Text] [Related]
4. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
5. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms.
Basturk O; Zamboni G; Klimstra DS; Capelli P; Andea A; Kamel NS; Adsay NV
Am J Surg Pathol; 2007 Mar; 31(3):363-70. PubMed ID: 17325477
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity in pancreatic endocrine tumors.
Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
[TBL] [Abstract][Full Text] [Related]
7. The utility of a novel antibody in the pathological diagnosis of pancreatic acinar cell carcinoma.
Yasumoto M; Hamabashiri M; Akiba J; Ogasawara S; Naito Y; Taira T; Nakayama M; Daicho A; Yamasaki F; Shimamatsu K; Ishida Y; Kaji R; Okabe Y; Nakashima O; Ohshima K; Nakashima M; Sata M; Yano H
J Clin Pathol; 2012 Apr; 65(4):327-32. PubMed ID: 22228907
[TBL] [Abstract][Full Text] [Related]
8. c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers.
La Rosa S; Bernasconi B; Vanoli A; Sciarra A; Notohara K; Albarello L; Casnedi S; Billo P; Zhang L; Tibiletti MG; Sessa F
Virchows Arch; 2018 Oct; 473(4):435-441. PubMed ID: 29721608
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers.
La Rosa S; Adsay V; Albarello L; Asioli S; Casnedi S; Franzi F; Marando A; Notohara K; Sessa F; Vanoli A; Zhang L; Capella C
Am J Surg Pathol; 2012 Dec; 36(12):1782-95. PubMed ID: 23026929
[TBL] [Abstract][Full Text] [Related]
10. Acinar cell cystadenocarcinoma of the pancreas: report of rare case and review of the literature.
Colombo P; Arizzi C; Roncalli M
Hum Pathol; 2004 Dec; 35(12):1568-71. PubMed ID: 15619219
[TBL] [Abstract][Full Text] [Related]
11. Comparative cytologic features of pancreatic acinar cell carcinoma and islet cell tumor.
Labate AM; Klimstra DL; Zakowski MF
Diagn Cytopathol; 1997 Feb; 16(2):112-6. PubMed ID: 9067100
[TBL] [Abstract][Full Text] [Related]
12. Acinar cell carcinoma arising in the stomach: a case report with literature review.
Sun Y; Wasserman PG
Hum Pathol; 2004 Feb; 35(2):263-5. PubMed ID: 14991547
[TBL] [Abstract][Full Text] [Related]
13. Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas.
Uhlig R; Contreras H; Weidemann S; Gorbokon N; Menz A; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Möller K; Bernreuther C; Lebok P; Sauter G; Wilczak W; Izbicki J; Perez D; Schrader J; Steurer S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R; Minner S; Jacobsen F; Clauditz TS
Am J Surg Pathol; 2022 Jan; 46(1):97-104. PubMed ID: 34889867
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Neoplasms With Acinar Differentiation: A Review of Pathologic and Molecular Features.
Thompson ED; Wood LD
Arch Pathol Lab Med; 2020 Jul; 144(7):808-815. PubMed ID: 31869246
[TBL] [Abstract][Full Text] [Related]
15. Insulinoma with fibrillar inclusions and acinar cell elements.
Ordóñez NG
Ultrastruct Pathol; 2001; 25(6):485-95. PubMed ID: 11783913
[TBL] [Abstract][Full Text] [Related]
16. Nonductal neoplasms of the pancreas.
Klimstra DS
Mod Pathol; 2007 Feb; 20 Suppl 1():S94-112. PubMed ID: 17486055
[TBL] [Abstract][Full Text] [Related]
17. Ductal and acinar differentiation in pancreatic endocrine tumors.
Kamisawa T; Tu Y; Egawa N; Ishiwata J; Tsuruta K; Okamoto A; Hayashi Y; Koike M; Yamaguchi T
Dig Dis Sci; 2002 Oct; 47(10):2254-61. PubMed ID: 12395898
[TBL] [Abstract][Full Text] [Related]
18. Pancreatoblastoma in an adult: its separation from acinar cell carcinoma.
Hoorens A; Gebhard F; Kraft K; Lemoine NR; Klöppel G
Virchows Arch; 1994; 424(5):485-90. PubMed ID: 8032529
[TBL] [Abstract][Full Text] [Related]
19. Aggressive approach to acinar cell carcinoma of the pancreas: a single-institution experience and a literature review.
Butturini G; Pisano M; Scarpa A; D'Onofrio M; Auriemma A; Bassi C
Langenbecks Arch Surg; 2011 Mar; 396(3):363-9. PubMed ID: 20803029
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic endocrine tumor with partial acinar cell differentiation.
Minakawa K; Oka K; Nihei T; Sando N; Oikawa H; Toda J; Hosokawa Y; Matsumoto T; Yanagisawa A
APMIS; 2006 Oct; 114(10):720-5. PubMed ID: 17004975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
